MTRY
Monterey Bio Acquisition Corporation [MTRY] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
MTRY Stock Summary
In the News
MTRY Financial details
Company Rating
-
Market Cap
48.3M
Income
-1.03M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-31.05
Forward P/E
-
PEG
-3.72
P/S
-
P/B
1.65
P/C
-
P/FCF
-49.23
Quick Ratio
0.18
Current Ratio
0.18
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.2
EPS next Y
-
EPS next Q
-
EPS this Y
300%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-0.32%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-5%
ROE
-5%
ROC
-0.1%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
10.21-12.0
52W High
-
52W Low
-
RSI
-
Rel Volume
1.23
Avg Volume
3.45K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 3.45K
- Market Capitalization 48.3M
- CEO Mr. Murat Omur
- Headquarters New York,NY,US
- IPO Date 2021-11-22
-
Website
https://www.montereybio.com 
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
